The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Urokinase for Injection Market Research Report 2024

Global Urokinase for Injection Market Research Report 2024

Publishing Date : Jul, 2022

License Type :
 

Report Code : 1546387

No of Pages : 70

Ask Your Query

Synopsis
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. 
Due to the COVID-19 pandemic, the global Urokinase for Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Urokinase for Injection market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Urokinase for Injection landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Urokinase Powder accounting for % of the Urokinase for Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Urokinase for Injection include NDPharm, Wanhua Biochem, Jiangxi Haoran Bio-Pharma and Jiangsu Aidea Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Urokinase for Injection in 2021.
This report focuses on Urokinase for Injection volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Urokinase for Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Urokinase for Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type

  • Urokinase Powder
  • Urokinase Solution

Segment by Application

  • Hospital
  • Clinic
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

By Company

  • NDPharm
  • Wanhua Biochem
  • Jiangxi Haoran Bio-Pharma
  • Jiangsu Aidea Pharmaceutical
Index

1 Urokinase for Injection Market Overview
1.1 Product Overview and Scope of Urokinase for Injection
1.2 Urokinase for Injection Segment by Type
1.2.1 Global Urokinase for Injection Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Urokinase for Injection Segment by Application
1.3.1 Global Urokinase for Injection Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Urokinase for Injection Market Size Estimates and Forecasts
1.4.1 Global Urokinase for Injection Revenue 2017-2028
1.4.2 Global Urokinase for Injection Sales 2017-2028
1.4.3 Urokinase for Injection Market Size by Region: 2017 Versus 2021 Versus 2028
2 Urokinase for Injection Market Competition by Manufacturers
2.1 Global Urokinase for Injection Sales Market Share by Manufacturers (2017-2022)
2.2 Global Urokinase for Injection Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Urokinase for Injection Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Urokinase for Injection Manufacturing Sites, Area Served, Product Type
2.5 Urokinase for Injection Market Competitive Situation and Trends
2.5.1 Urokinase for Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Urokinase for Injection Players Market Share by Revenue
2.5.3 Global Urokinase for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Urokinase for Injection Retrospective Market Scenario by Region
3.1 Global Urokinase for Injection Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Urokinase for Injection Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Urokinase for Injection Market Facts & Figures by Country
3.3.1 North America Urokinase for Injection Sales by Country
3.3.2 North America Urokinase for Injection Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Urokinase for Injection Market Facts & Figures by Country
3.4.1 Europe Urokinase for Injection Sales by Country
3.4.2 Europe Urokinase for Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Urokinase for Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Urokinase for Injection Sales by Region
3.5.2 Asia Pacific Urokinase for Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Urokinase for Injection Market Facts & Figures by Country
3.6.1 Latin America Urokinase for Injection Sales by Country
3.6.2 Latin America Urokinase for Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Urokinase for Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Urokinase for Injection Sales by Country
3.7.2 Middle East and Africa Urokinase for Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Urokinase for Injection Historic Market Analysis by Type
4.1 Global Urokinase for Injection Sales Market Share by Type (2017-2022)
4.2 Global Urokinase for Injection Revenue Market Share by Type (2017-2022)
4.3 Global Urokinase for Injection Price by Type (2017-2022)
5 Global Urokinase for Injection Historic Market Analysis by Application
5.1 Global Urokinase for Injection Sales Market Share by Application (2017-2022)
5.2 Global Urokinase for Injection Revenue Market Share by Application (2017-2022)
5.3 Global Urokinase for Injection Price by Application (2017-2022)
6 Key Companies Profiled
6.1 NDPharm
6.1.1 NDPharm Corporation Information
6.1.2 NDPharm Description and Business Overview
6.1.3 NDPharm Urokinase for Injection Sales, Revenue and Gross Margin (2017-2022)
6.1.4 NDPharm Urokinase for Injection Product Portfolio
6.1.5 NDPharm Recent Developments/Updates
6.2 Wanhua Biochem
6.2.1 Wanhua Biochem Corporation Information
6.2.2 Wanhua Biochem Description and Business Overview
6.2.3 Wanhua Biochem Urokinase for Injection Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Wanhua Biochem Urokinase for Injection Product Portfolio
6.2.5 Wanhua Biochem Recent Developments/Updates
6.3 Jiangxi Haoran Bio-Pharma
6.3.1 Jiangxi Haoran Bio-Pharma Corporation Information
6.3.2 Jiangxi Haoran Bio-Pharma Description and Business Overview
6.3.3 Jiangxi Haoran Bio-Pharma Urokinase for Injection Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Jiangxi Haoran Bio-Pharma Urokinase for Injection Product Portfolio
6.3.5 Jiangxi Haoran Bio-Pharma Recent Developments/Updates
6.4 Jiangsu Aidea Pharmaceutical
6.4.1 Jiangsu Aidea Pharmaceutical Corporation Information
6.4.2 Jiangsu Aidea Pharmaceutical Description and Business Overview
6.4.3 Jiangsu Aidea Pharmaceutical Urokinase for Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Jiangsu Aidea Pharmaceutical Urokinase for Injection Product Portfolio
6.4.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates
7 Urokinase for Injection Manufacturing Cost Analysis
7.1 Urokinase for Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Urokinase for Injection
7.4 Urokinase for Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Urokinase for Injection Distributors List
8.3 Urokinase for Injection Customers
9 Urokinase for Injection Market Dynamics
9.1 Urokinase for Injection Industry Trends
9.2 Urokinase for Injection Market Drivers
9.3 Urokinase for Injection Market Challenges
9.4 Urokinase for Injection Market Restraints
10 Global Market Forecast
10.1 Urokinase for Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Urokinase for Injection by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Urokinase for Injection by Type (2023-2028)
10.2 Urokinase for Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Urokinase for Injection by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Urokinase for Injection by Application (2023-2028)
10.3 Urokinase for Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Urokinase for Injection by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Urokinase for Injection by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Urokinase for Injection Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
Table 2. Global Urokinase for Injection Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
Table 3. Global Urokinase for Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Urokinase for Injection Market Competitive Situation by Manufacturers in 2021
Table 5. Global Urokinase for Injection Sales (Kg) of Key Manufacturers (2017-2022)
Table 6. Global Urokinase for Injection Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Urokinase for Injection Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Urokinase for Injection Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Urokinase for Injection Average Price (USD/Kg) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Urokinase for Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Urokinase for Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Urokinase for Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urokinase for Injection as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Urokinase for Injection Sales by Region (2017-2022) & (Kg)
Table 16. Global Urokinase for Injection Sales Market Share by Region (2017-2022)
Table 17. Global Urokinase for Injection Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Urokinase for Injection Revenue Market Share by Region (2017-2022)
Table 19. North America Urokinase for Injection Sales by Country (2017-2022) & (Kg)
Table 20. North America Urokinase for Injection Sales Market Share by Country (2017-2022)
Table 21. North America Urokinase for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Urokinase for Injection Revenue Market Share by Country (2017-2022)
Table 23. Europe Urokinase for Injection Sales by Country (2017-2022) & (Kg)
Table 24. Europe Urokinase for Injection Sales Market Share by Country (2017-2022)
Table 25. Europe Urokinase for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Urokinase for Injection Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Urokinase for Injection Sales by Region (2017-2022) & (Kg)
Table 28. Asia Pacific Urokinase for Injection Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Urokinase for Injection Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Urokinase for Injection Revenue Market Share by Region (2017-2022)
Table 31. Latin America Urokinase for Injection Sales by Country (2017-2022) & (Kg)
Table 32. Latin America Urokinase for Injection Sales Market Share by Country (2017-2022)
Table 33. Latin America Urokinase for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Urokinase for Injection Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Urokinase for Injection Sales by Country (2017-2022) & (Kg)
Table 36. Middle East and Africa Urokinase for Injection Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Urokinase for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Urokinase for Injection Revenue Market Share by Country (2017-2022)
Table 39. Global Urokinase for Injection Sales by Type (2017-2022) & (Kg)
Table 40. Global Urokinase for Injection Sales Market Share by Type (2017-2022)
Table 41. Global Urokinase for Injection Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Urokinase for Injection Revenue Share by Type (2017-2022)
Table 43. Global Urokinase for Injection Price by Type (2017-2022) & (USD/Kg)
Table 44. Global Urokinase for Injection Sales (Kg) by Application (2017-2022)
Table 45. Global Urokinase for Injection Sales Market Share by Application (2017-2022)
Table 46. Global Urokinase for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Urokinase for Injection Revenue Share by Application (2017-2022)
Table 48. Global Urokinase for Injection Price by Application (2017-2022) & (USD/Kg)
Table 49. NDPharm Corporation Information
Table 50. NDPharm Description and Business Overview
Table 51. NDPharm Urokinase for Injection Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 52. NDPharm Urokinase for Injection Product
Table 53. NDPharm Recent Developments/Updates
Table 54. Wanhua Biochem Corporation Information
Table 55. Wanhua Biochem Description and Business Overview
Table 56. Wanhua Biochem Urokinase for Injection Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 57. Wanhua Biochem Urokinase for Injection Product
Table 58. Wanhua Biochem Recent Developments/Updates
Table 59. Jiangxi Haoran Bio-Pharma Corporation Information
Table 60. Jiangxi Haoran Bio-Pharma Description and Business Overview
Table 61. Jiangxi Haoran Bio-Pharma Urokinase for Injection Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 62. Jiangxi Haoran Bio-Pharma Urokinase for Injection Product
Table 63. Jiangxi Haoran Bio-Pharma Recent Developments/Updates
Table 64. Jiangsu Aidea Pharmaceutical Corporation Information
Table 65. Jiangsu Aidea Pharmaceutical Description and Business Overview
Table 66. Jiangsu Aidea Pharmaceutical Urokinase for Injection Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 67. Jiangsu Aidea Pharmaceutical Urokinase for Injection Product
Table 68. Jiangsu Aidea Pharmaceutical Recent Developments/Updates
Table 69. Production Base and Market Concentration Rate of Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Urokinase for Injection Distributors List
Table 72. Urokinase for Injection Customers List
Table 73. Urokinase for Injection Market Trends
Table 74. Urokinase for Injection Market Drivers
Table 75. Urokinase for Injection Market Challenges
Table 76. Urokinase for Injection Market Restraints
Table 77. Global Urokinase for Injection Sales Forecast by Type (2023-2028) & (Kg)
Table 78. Global Urokinase for Injection Sales Market Share Forecast by Type (2023-2028)
Table 79. Global Urokinase for Injection Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 80. Global Urokinase for Injection Revenue Market Share Forecast by Type (2023-2028)
Table 81. Global Urokinase for Injection Sales Forecast by Application (2023-2028) & (Kg)
Table 82. Global Urokinase for Injection Sales Market Share Forecast by Application (2023-2028)
Table 83. Global Urokinase for Injection Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 84. Global Urokinase for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 85. Global Urokinase for Injection Sales Forecast by Region (2023-2028) & (Kg)
Table 86. Global Urokinase for Injection Sales Market Share Forecast by Region (2023-2028)
Table 87. Global Urokinase for Injection Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 88. Global Urokinase for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Urokinase for Injection
Figure 2. Global Urokinase for Injection Market Share by Type in 2021 & 2028
Figure 3. Urokinase Powder Product Picture
Figure 4. Urokinase Solution Product Picture
Figure 5. Global Urokinase for Injection Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Urokinase for Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Urokinase for Injection Market Size (2017-2028) & (US$ Million)
Figure 11. Global Urokinase for Injection Sales (2017-2028) & (Kg)
Figure 12. Urokinase for Injection Sales Share by Manufacturers in 2021
Figure 13. Global Urokinase for Injection Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Urokinase for Injection Players: Market Share by Revenue in 2021
Figure 15. Urokinase for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Urokinase for Injection Sales Market Share by Region (2017-2022)
Figure 17. Global Urokinase for Injection Sales Market Share by Region in 2021
Figure 18. Global Urokinase for Injection Revenue Market Share by Region (2017-2022)
Figure 19. Global Urokinase for Injection Revenue Market Share by Region in 2021
Figure 20. U.S. Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Philippines Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Vietnam Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. U.A.E Urokinase for Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Urokinase for Injection by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Urokinase for Injection
Figure 46. Manufacturing Process Analysis of Urokinase for Injection
Figure 47. Urokinase for Injection Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock